Our data demonstrates that VPA enhances the susceptibility of pancreatic cancer cells to NK cell-mediated cytotoxicity both in vitro and in vivo by upregulating the expression of MICA and MICB via activation of the PI3K/Akt pathway. Here, MICB is linked to pancreatic neoplasm.